Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

CF101

orally q12h

DRUG

Placebo

orally q12h

Trial Locations (26)

1612

Clinic of Rheumatology at MHAT 'Sveti Ivan Rilski', Sofia

4002

Clinic of Rheumatology at MHAT 'Sveti Georgi', Plovdiv

6000

Second Clinic of Internal Diseases at MHAT 'Stara Zagora', Stara Zagora

9010

Clinic of Rheumatology at MHAT 'Sveta Marina' - Varna, Varna

11000

Institute of Rheumatology - Belgrade, Belgrade

12850

Institute of Rheumatology, Prague

18205

Institute for Prevention, Treatment, and Rehabilitation of Rheumatoid and Cardiovascular Diseases Niska Banja, Niška Banja

20607

Niepubliczny Zaklad Opieki Zdrowotnej, Lublin

21018

Vinnitsya Regional Clinical Hospital, Vinnycia

31096

Rambam Medical Center, Haifa

44281

Meir Medical Center, Kfar Saba

50005

University Hospital Hradec Kralove, Hradec Králové

71252

Samodzielny Publiczny Szpital Kliniczny Nr 1 P.A.M. w Szczecinie, Szczecin

76001

Rheumotology Out-patient Clinic, Zlín

78278

Barzilai Medical Center, Ashkelon

81967

Wojewodzki Zespol Reumatologiczny w Sopocie, Sopot

82300

Wojewodzki Szpital Zespolony w Elblagu, Elblag

83114

Central Municipal Clinical Hospital nº1, Donetsk

87100

"Niepubliczny Zaklad Opieki Zdrowotnej NASZ LEKARZ", Torun

Unknown

Clinic of internal diseases at NMTH 'Tzar Boris Treti', Sofia

Haemek Medical Center, Afula

Hadassah Har-Hazofim Medical Center, Jerusalem

01023

Kyiv Central Municipal Hospital, Kiev

01103

City Clinical Hospital N12, Kiev

03680

National Scientific Centre of AMS of Ukraine, Kiev

04053

O.O. Bogomolets National Medical University, Kiev

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Can-Fite BioPharma

INDUSTRY